NYSE - Nasdaq Real Time Price USD

Envista Holdings Corporation (NVST)

Compare
21.35 -0.03 (-0.16%)
As of 11:19 AM EST. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Stephen Keller Vice President of Investor Relations 453.73k -- 1974
Mr. Mark E. Nance J.D. Senior VP, General Counsel & Secretary 592.96k -- 1968
Mr. Paul A. Keel CEO & Director -- -- 1970
Mr. Eric D. Hammes Chief Financial Officer -- -- 1975
Mr. Faez Kaabi VP, Chief Accounting Officer & Corporate Controller -- -- 1969
Mr. Andrew Chen Chief Information Officer -- -- --
Paul Sumilas Chief Compliance Officer -- -- --
Mr. Mischa M. Reis Senior Vice President of Strategy & Corporate Development -- -- 1972
Mr. Suraj Satpathy Chief Human Resources officer -- -- --
Mr. Filippo Impieri Senior Vice President of Emerging Markets -- -- --

Envista Holdings Corporation

Building E
200 South Kraemer Boulevard
Brea, CA 92821-6208
United States
714 817 7000 https://envistaco.com
Sector:?
Healthcare
Full Time Employees:?
12,800

Description

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Corporate Governance

Envista Holdings Corporation’s ISS Governance QualityScore as of November 1, 2024 is 4. The pillar scores are Audit: 4; Board: 5; Shareholder Rights: 4; Compensation: 4.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 5, 2025 at 10:59 AM UTC - February 10, 2025 at 12:00 PM UTC

Envista Holdings Corporation Earnings Date

Recent Events

November 20, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 30, 2024 at 9:00 PM UTC

Q3 2024 Earnings Call

October 30, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

September 19, 2024 at 12:00 AM UTC

S-8: Offering Registrations

August 7, 2024 at 9:00 PM UTC

Q2 2024 Earnings Call

August 7, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 15, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 13, 2024 at 12:00 AM UTC

11-K: Annual report of employee stock purchase

May 30, 2024 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

May 24, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers